Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-2-methyl-1-ethanol
2. 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidineethanol
3. 61 91 Rc
4. Alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine Ethanol
5. Ifenprodil
6. Ifenprodil Hydrochloride
7. Ifenprodil Hydrochloride, (+-)-isomer
8. Ifenprodil Tartrate
9. Ifenprodil Tartrate (1:1), (r*,s*)-(+-)-(r-(r*,r*))-isomer
10. Ifenprodil Tartrate (1:1), (r-(r*,r*))-isomer
11. Ifenprodil Tartrate (2:1), (r-(r*,r*))-isomer
12. Ifenprodil, (r*,s*)-(+-)-isomer
13. Ifenprodil, Tartrate(r-(r*,r*))-isomer
1. Dilvax
2. Ifenprodil Tartrate
3. Ifenprodil L-(+)-tartrate
4. 66157-43-5
5. Cerocral
6. Validex
7. 4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol;(2r,3r)-2,3-dihydroxybutanedioate
8. Ifenprodil Tartrate (2:1)
9. Ifenprodil L-(+)-tartrate (2:1)
10. 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol Tartrate (2:1)
11. 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidineethanol Tartrate
12. 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidine-ethanol-(l)-(+)-tartrate
13. Piperidineethanol, Alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-, Tartrate (2:1)
14. 1-piperidineethanol, 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-, Tartrate (salt) (2:1)
| Molecular Weight | 799.0 g/mol |
|---|---|
| Molecular Formula | C46H58N2O10-2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 11 |
| Exact Mass | 798.40914605 g/mol |
| Monoisotopic Mass | 798.40914605 g/mol |
| Topological Polar Surface Area | 208 Ų |
| Heavy Atom Count | 58 |
| Formal Charge | -2 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
JDMF
Japanese Pharmacopoeia Ifenprodil Tartrate For manufacturing only
Registration Number : 218MF10594
Registrant's Address : 1-1-2 Nishinomiyahama, Nishinomiya City, Hyogo Prefecture
Initial Date of Registration : 2006-06-22
Latest Date of Registration : 2006-06-22
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
93
PharmaCompass offers a list of Cerocral API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cerocral manufacturer or Cerocral supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cerocral manufacturer or Cerocral supplier.
PharmaCompass also assists you with knowing the Cerocral API Price utilized in the formulation of products. Cerocral API Price is not always fixed or binding as the Cerocral Price is obtained through a variety of data sources. The Cerocral Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Validex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Validex, including repackagers and relabelers. The FDA regulates Validex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Validex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Validex supplier is an individual or a company that provides Validex active pharmaceutical ingredient (API) or Validex finished formulations upon request. The Validex suppliers may include Validex API manufacturers, exporters, distributors and traders.
click here to find a list of Validex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Validex Drug Master File in Japan (Validex JDMF) empowers Validex API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Validex JDMF during the approval evaluation for pharmaceutical products. At the time of Validex JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Validex suppliers with JDMF on PharmaCompass.
Validex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Validex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Validex GMP manufacturer or Validex GMP API supplier for your needs.
A Validex CoA (Certificate of Analysis) is a formal document that attests to Validex's compliance with Validex specifications and serves as a tool for batch-level quality control.
Validex CoA mostly includes findings from lab analyses of a specific batch. For each Validex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Validex may be tested according to a variety of international standards, such as European Pharmacopoeia (Validex EP), Validex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Validex USP).
